NCT04577885View on ClinicalTrials.gov

A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

September 20, 2020

Conditions
Healthy
Interventions
DRUG

SHR2554 and Rifampin

Single-dose oral administration of SHR2554 and multiple-dose oral administration of Rifampin Capsules

Trial Locations (1)

Unknown

Jiangsu HengRui Medicine Co., Ltd., Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04577885 - A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects | Biotech Hunter | Biotech Hunter